They suggest novel roles of FGF21 signaling and metabolic reprogramming in suppressing mammary tumors that rise from luminal epithelial cells in the ducts and lobules surrounded mostly by FGF21-responsive adipocytes. Here, FGF21 is linked to breast cancer.